Immix Biopharma, Inc. Common Stock (IMMX) Stock Price, Quote & AI Analysis
Live IMMX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Immix Biopharma, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Immix Biopharma, Inc. Common Stock (IMMX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Immix Biopharma, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Immix Biopharma, Inc. Common Stock Overview
Company information
Company Overview
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Immix Biopharma, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...